Kadcyla 50242-0087

Generic: Ado-Trastuzumab Emtansine

Product NDC

50242-0087

Manufacturer: Genentech, Inc.
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: February 22, 2013
Listing Expires: December 31, 2027
Application: BLA125427

Need to source Kadcyla? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Trastuzumab Emtansine	20 mg/mL

Packaging Options(1)

50242-0087-01

1 VIAL, SINGLE-USE in 1 CARTON (50242-087-01) / 8 mL in 1 VIAL, SINGLE-USE

View →